Home » Topics » Regulatory

Regulatory
RSS

Simdax approved in Sweden for severe heart failure

Sep. 28, 2000

Combinations with synergistic antitumor activity claimed by Pharmacia

Sep. 27, 2000

FDA approves Trisenox for APL only three years after U.S. studies began

Sep. 27, 2000

Levaquin tablets/injection approved for new indication in U.S.

Sep. 22, 2000

Once-daily tramadol enters phase III

Sep. 21, 2000

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Sep. 20, 2000

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

New HIV treatment option approved by FDA

Sep. 19, 2000

New therapy for AIDS wasting receives orphan product designation from E.C.

Sep. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ASH 2025: New blood cancer therapies trump chemo, older drugs
BioWorld
Targeted therapies and immunotherapies continue to show better results than chemotherapy in investigator-initiated and company-sponsored cancer trials, and newer...